Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women

Azusa Hara, Shizuka Sasazuki, Manami Inoue, Tsutomu Miura, Motoki Iwasaki, Norie Sawada, Taichi Shimazu, Taiki Yamaji, Shoichiro Tsugane

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The incidence of gastric cancer throughout the world is ~2-3 times higher in men than in women. Previous research suggested that isoflavones, which are structurally similar to 17b-estradiol, may prevent gastric cancer. Based on a large, population-based, prospective study, we recently reported a null association between dietary isoflavone intake and gastric cancer. However, epidemiologic studies using blood concentrations of isoflavones might better reflect the effect of isoflavones on gastric cancer carcinogenesis than dietary assessment. We therefore conducted a nested case-control study within the Japan Public Health Center-Based Prospective Study. Participants were followed-up from 1990 to 2004. Among 36,745 participantswho answered the baseline questionnaire and provided blood samples, 483 gastric cancer casesmatched to 483 controlswere used in the analysis. ORs and 95%CIswere estimated with a conditional logistic regression model. The overall distribution of plasma isoflavone concentrations was not associated with the development of gastric cancer. Compared with groups with the lowest plasma concentrations (reference groups), the groups with the highest daidzein and genistein concentrations had adjusted ORs and 95% CIs of 1.11 (0.74-1.66; P-trend = 0.6) and 0.96 (0.64-1.44; P-trend = 0.9), respectively. The results did not change when analysis was based on sex, subsite, or histological type. We found no association of plasma isoflavone concentrations with gastric cancer risk. Our data support the previously observed null association between isoflavone intake and gastric cancer risk.

Original languageEnglish
Pages (from-to)1293-1298
Number of pages6
JournalJournal of Nutrition
Volume143
Issue number8
DOIs
Publication statusPublished - 2013 Aug 15
Externally publishedYes

Fingerprint

Isoflavones
Stomach Neoplasms
Logistic Models
Prospective Studies
Genistein
Case-Control Studies
Epidemiologic Studies
Estradiol
Japan
Carcinogenesis
Public Health
Incidence
Research

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women. / Hara, Azusa; Sasazuki, Shizuka; Inoue, Manami; Miura, Tsutomu; Iwasaki, Motoki; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Tsugane, Shoichiro.

In: Journal of Nutrition, Vol. 143, No. 8, 15.08.2013, p. 1293-1298.

Research output: Contribution to journalArticle

Hara, A, Sasazuki, S, Inoue, M, Miura, T, Iwasaki, M, Sawada, N, Shimazu, T, Yamaji, T & Tsugane, S 2013, 'Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women', Journal of Nutrition, vol. 143, no. 8, pp. 1293-1298. https://doi.org/10.3945/jn.113.175505
Hara, Azusa ; Sasazuki, Shizuka ; Inoue, Manami ; Miura, Tsutomu ; Iwasaki, Motoki ; Sawada, Norie ; Shimazu, Taichi ; Yamaji, Taiki ; Tsugane, Shoichiro. / Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women. In: Journal of Nutrition. 2013 ; Vol. 143, No. 8. pp. 1293-1298.
@article{1d2311ade6c0433b8abd1bf8b85c739a,
title = "Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women",
abstract = "The incidence of gastric cancer throughout the world is ~2-3 times higher in men than in women. Previous research suggested that isoflavones, which are structurally similar to 17b-estradiol, may prevent gastric cancer. Based on a large, population-based, prospective study, we recently reported a null association between dietary isoflavone intake and gastric cancer. However, epidemiologic studies using blood concentrations of isoflavones might better reflect the effect of isoflavones on gastric cancer carcinogenesis than dietary assessment. We therefore conducted a nested case-control study within the Japan Public Health Center-Based Prospective Study. Participants were followed-up from 1990 to 2004. Among 36,745 participantswho answered the baseline questionnaire and provided blood samples, 483 gastric cancer casesmatched to 483 controlswere used in the analysis. ORs and 95{\%}CIswere estimated with a conditional logistic regression model. The overall distribution of plasma isoflavone concentrations was not associated with the development of gastric cancer. Compared with groups with the lowest plasma concentrations (reference groups), the groups with the highest daidzein and genistein concentrations had adjusted ORs and 95{\%} CIs of 1.11 (0.74-1.66; P-trend = 0.6) and 0.96 (0.64-1.44; P-trend = 0.9), respectively. The results did not change when analysis was based on sex, subsite, or histological type. We found no association of plasma isoflavone concentrations with gastric cancer risk. Our data support the previously observed null association between isoflavone intake and gastric cancer risk.",
author = "Azusa Hara and Shizuka Sasazuki and Manami Inoue and Tsutomu Miura and Motoki Iwasaki and Norie Sawada and Taichi Shimazu and Taiki Yamaji and Shoichiro Tsugane",
year = "2013",
month = "8",
day = "15",
doi = "10.3945/jn.113.175505",
language = "English",
volume = "143",
pages = "1293--1298",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "8",

}

TY - JOUR

T1 - Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women

AU - Hara, Azusa

AU - Sasazuki, Shizuka

AU - Inoue, Manami

AU - Miura, Tsutomu

AU - Iwasaki, Motoki

AU - Sawada, Norie

AU - Shimazu, Taichi

AU - Yamaji, Taiki

AU - Tsugane, Shoichiro

PY - 2013/8/15

Y1 - 2013/8/15

N2 - The incidence of gastric cancer throughout the world is ~2-3 times higher in men than in women. Previous research suggested that isoflavones, which are structurally similar to 17b-estradiol, may prevent gastric cancer. Based on a large, population-based, prospective study, we recently reported a null association between dietary isoflavone intake and gastric cancer. However, epidemiologic studies using blood concentrations of isoflavones might better reflect the effect of isoflavones on gastric cancer carcinogenesis than dietary assessment. We therefore conducted a nested case-control study within the Japan Public Health Center-Based Prospective Study. Participants were followed-up from 1990 to 2004. Among 36,745 participantswho answered the baseline questionnaire and provided blood samples, 483 gastric cancer casesmatched to 483 controlswere used in the analysis. ORs and 95%CIswere estimated with a conditional logistic regression model. The overall distribution of plasma isoflavone concentrations was not associated with the development of gastric cancer. Compared with groups with the lowest plasma concentrations (reference groups), the groups with the highest daidzein and genistein concentrations had adjusted ORs and 95% CIs of 1.11 (0.74-1.66; P-trend = 0.6) and 0.96 (0.64-1.44; P-trend = 0.9), respectively. The results did not change when analysis was based on sex, subsite, or histological type. We found no association of plasma isoflavone concentrations with gastric cancer risk. Our data support the previously observed null association between isoflavone intake and gastric cancer risk.

AB - The incidence of gastric cancer throughout the world is ~2-3 times higher in men than in women. Previous research suggested that isoflavones, which are structurally similar to 17b-estradiol, may prevent gastric cancer. Based on a large, population-based, prospective study, we recently reported a null association between dietary isoflavone intake and gastric cancer. However, epidemiologic studies using blood concentrations of isoflavones might better reflect the effect of isoflavones on gastric cancer carcinogenesis than dietary assessment. We therefore conducted a nested case-control study within the Japan Public Health Center-Based Prospective Study. Participants were followed-up from 1990 to 2004. Among 36,745 participantswho answered the baseline questionnaire and provided blood samples, 483 gastric cancer casesmatched to 483 controlswere used in the analysis. ORs and 95%CIswere estimated with a conditional logistic regression model. The overall distribution of plasma isoflavone concentrations was not associated with the development of gastric cancer. Compared with groups with the lowest plasma concentrations (reference groups), the groups with the highest daidzein and genistein concentrations had adjusted ORs and 95% CIs of 1.11 (0.74-1.66; P-trend = 0.6) and 0.96 (0.64-1.44; P-trend = 0.9), respectively. The results did not change when analysis was based on sex, subsite, or histological type. We found no association of plasma isoflavone concentrations with gastric cancer risk. Our data support the previously observed null association between isoflavone intake and gastric cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=84881336305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881336305&partnerID=8YFLogxK

U2 - 10.3945/jn.113.175505

DO - 10.3945/jn.113.175505

M3 - Article

VL - 143

SP - 1293

EP - 1298

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 8

ER -